BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10993020)

  • 1. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials of implantable defibrillators.
    Myerburg RJ; Castellanos A
    N Engl J Med; 1997 Nov; 337(22):1621-3. PubMed ID: 9371860
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R
    Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
    Böcker D; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
    Peters NS
    Eur Heart J; 1999 Mar; 20(5):321-3. PubMed ID: 10206376
    [No Abstract]   [Full Text] [Related]  

  • 7. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
    Ferrari R; Cinca J; Marber M
    Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study.
    Greene HL
    Am Heart J; 1994 Apr; 127(4 Pt 2):1171-8. PubMed ID: 8160597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillators--for whom?
    Connolly SJ
    Lancet; 1998 Aug; 352(9125):338-40. PubMed ID: 9717916
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiarrhythmics Versus Implantable Defibrillators (AVID)--rationale, design, and methods.
    Hallstrom AP; Greene HL; Wyse DG; Zipes D; Epstein AE; Domanski MJ; Schron EB;
    Am J Cardiol; 1995 Mar; 75(7):470-5. PubMed ID: 7863991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators.
    Connolly SJ; Gent M; Roberts RS; Dorian P; Green MS; Klein GJ; Mitchell LB; Sheldon RS; Roy D
    Am J Cardiol; 1993 Nov; 72(16):103F-108F. PubMed ID: 8237822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).
    Siebels J; Kuck KH
    Am Heart J; 1994 Apr; 127(4 Pt 2):1139-44. PubMed ID: 8160593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-drug therapy of ventricular tachycardia/ventricular fibrillation].
    Steinbach K; Frohner K; Hief C; Kaltenbrunner W; Nürnberg M; Podczeck A; Veit F
    Wien Med Wochenschr; 1992; 142(15-16):367-70. PubMed ID: 1481542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate use of the implantable cardioverter defibrillator: a Canadian perspective. Canadian Working Group on Cardiac Pacing.
    Yee R; Connolly SJ; Gillis AM
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):1-4. PubMed ID: 9990594
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of incessant ventricular tachycardia in a 39-year-old woman with cardiomyopathy.
    Schuster MM
    Am J Crit Care; 1997 Nov; 6(6):467-71. PubMed ID: 9354226
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Exner DV; Reiffel JA; Epstein AE; Ledingham R; Reiter MJ; Yao Q; Duff HJ; Follmann D; Schron E; Greene HL; Carlson MD; Brodsky MA; Akiyama T; Baessler C; Anderson JL
    J Am Coll Cardiol; 1999 Aug; 34(2):325-33. PubMed ID: 10440140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of ventricular arrhythmias.
    Anderson MH
    Br J Hosp Med; 1994 Sep 7-20; 52(5):204-9. PubMed ID: 7529627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest?
    Zipes DP
    Circulation; 1995 Apr; 91(8):2115-7. PubMed ID: 7697837
    [No Abstract]   [Full Text] [Related]  

  • 19. Why the antiarrhythmics versus implantable defibrillator (AVID) trial sets the wrong precedent.
    Fogoros RN
    Am J Cardiol; 1997 Sep; 80(6):762-5. PubMed ID: 9315584
    [No Abstract]   [Full Text] [Related]  

  • 20. Learning more about indications for implantable cardioverter-defibrillators.
    Myerburg RJ; Castellanos A
    J Am Coll Cardiol; 1999 Oct; 34(4):1096-8. PubMed ID: 10520796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.